Stability of sulfadiazine oral liquids prepared from tablets and powder.
暂无分享,去创建一个
[1] A. Leone,et al. Congenital toxoplasmosis: 10-year follow up , 1995, European Journal of Pediatrics.
[2] K. Vutova,et al. Congenital toxoplasmosis: eye manifestations in infants and children , 2002, Annals of tropical paediatrics.
[3] H. Qublan,et al. Toxoplasmosis and habitual abortion , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[4] P. Thulliez,et al. Traitement de la toxoplasmose congénitale non sévère par sulfadiazine et pyriméthamine en continu pendant un an : à propos de 46 cas , 2002 .
[5] J. Magny,et al. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[6] N. Furusawa,et al. Matrix solid-phase dispersion extraction and high-performance liquid chromatographic determination of residual sulfonamides in chicken. , 2001, Journal of chromatography. A.
[7] B. Stray-Pedersen,et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. , 1999, American journal of obstetrics and gynecology.
[8] A. Berrebi,et al. Termination of pregnancy for maternal toxoplasmosis , 1994, The Lancet.
[9] F. Pratlong,et al. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy , 1994, Prenatal diagnosis.
[10] N. Anaizi,et al. Instability of aqueous captopril solutions. , 1993, American journal of hospital pharmacy.
[11] C. Wilson,et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. , 1980, Pediatrics.
[12] Martindale.,et al. THE EXTRA PHARMACOPOEIA , 1937 .